More evidence is needed to confirm the benefits and risks of many botanicals in dermatology

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.7, 2011-07, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Splitting Antidepressant Medications: More Studies Are Needed To Confirm Clinical Outcomes and Potential Savings

By Donoghue J.  

CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. : 359-360

Adis International

Access to resources Recommend Favorite

Alteplase in acute ischaemic stroke: more evidence needed

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Benefits and Risks of Pharmacotherapy for Dysthymia: A Systematic Appraisal of the Evidence

By De Lima M.S.  

Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. : 55-64

Adis International

Access to resources Recommend Favorite

Off-Label Trazodone Prescription: Evidence, Benefits and Risks

By  

Current Pharmaceutical Design, Vol. 21, Iss. 23, 2015-01 ,pp. : 3343-3351

Bentham Science Publishers

Access to resources Recommend Favorite

Benefits and Risks of Antipsychotic Polypharmacy: An Evidence-Based Review of the Literature

By Tranulis Constantin  

Drug Safety, Vol. 31, Iss. 1, 2008-01 ,pp. : 7-20

Adis International

Access to resources Recommend Favorite